A main target of miR-101 in Chondrosarcoma is TIMP-3 (tissue inhibitor of metalloproteinases-3), a critical regulator of metalloproteinase activity that preserves extracellular matrix integrity. This evidence concerns the gene TIMP3 and chondrosarcoma.